Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma

NCT05268614 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Oropharyngeal Squamous Cell Carcinoma

Interventions

RADIATION: Radiation therapy
DRUG: Cisplatin

Sponsor

University of Florida

Collaborators

[object Object]